Patents Represented by Attorney Gregory D. Ferrar
  • Patent number: 6066718
    Abstract: The invention relates to reshaped human monoclonal antibodies directed against isotypic determinants of immunoglobulin E (IgE), direct equivalents and derivatives of said antibodies. The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
    Type: Grant
    Filed: September 27, 1993
    Date of Patent: May 23, 2000
    Assignees: Novartis Corporation, Tanox Biosystems, Inc.
    Inventors: Norman Hardman, Frank Kolbinger, Jose Saldanha